---
title: "Organon & Co. Announces CEO Resignation and Interim Appointments"
description: "On October 26, 2025, Organon & Co. announced the resignation of CEO Kevin Ali amid an investigation. Joseph Morrissey has been appointed as Interim CEO, and Carrie S. Cox as Executive Chair, effective"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/262887528.md"
published_at: "2025-10-27T11:45:00.000Z"
---

# Organon & Co. Announces CEO Resignation and Interim Appointments

> On October 26, 2025, Organon & Co. announced the resignation of CEO Kevin Ali amid an investigation. Joseph Morrissey has been appointed as Interim CEO, and Carrie S. Cox as Executive Chair, effective the same day. The reasons for Ali's resignation are linked to the ongoing investigation, while details regarding the replacements and committee role changes remain undisclosed.

On October 26, 2025, Organon & Co. announced the resignation of Kevin Ali as CEO and Board member amid an investigation. Joseph Morrissey has been appointed as Interim CEO, and Carrie S. Cox as Executive Chair.

**Individual**

Kevin Ali

Joseph Morrissey

Carrie S. Cox

**Role**

CEO, Board Member

Interim CEO

Executive Chair

**Type of Change**

Resigned

Appointed

Appointed

**Effective Date**

Oct 26, 2025

Oct 26, 2025

Oct 26, 2025

**Reason**

Investigation

N/A

N/A

**Replacement Info**

Joseph Morrissey

Not disclosed

Not disclosed

**Background Details**

N/A

Former EVP, Head of Manufacturing & Supply

N/A

**Board/Committee Role Changes**

Not disclosed

Not disclosed

Not disclosed

Original SEC Filing: Organon & Co. \[ OGN \] - 8-K - Oct. 27, 2025

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [OGN.US - Organon](https://longbridge.com/en/quote/OGN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| OrganoClick Reports Q4 EBIT Loss At SEK 18.34 Million | OrganoClick AB :Q4 GROSS MARGIN -24.4%Q4 REVENUE SEK 18.37 MILLIONQ4 EBIT SEK -18.34 MILLIONPROPOSES THAT NO DIVIDEND WI | [Link](https://longbridge.com/en/news/275717331.md) |
| Organon Q4 Earnings Preview: Cautious view amid weak year | Organon (OGN) will announce Q4 earnings on February 12th. The company has seen a nearly 50% drop in shares over the past | [Link](https://longbridge.com/en/news/275635252.md) |
| Organon & Co. to Release Third Quarter 2025 Results | Organon & Co. will announce its third quarter 2025 financial results on November 10, 2025, before a webcast and conferen | [Link](https://longbridge.com/en/news/264650854.md) |
| Organon Amends Filing to Disclose Executive Chair Compensation | Organon & Co. has amended its Form 8-K filed on October 27, 2025, to disclose the compensation details of Executive Chai | [Link](https://longbridge.com/en/news/263603866.md) |
| Shoucheng Holdings investiert in MarveLab | Shoucheng Holdings Ltd. has announced that a fund managed by its wholly-owned subsidiary has invested in Silver Island F | [Link](https://longbridge.com/en/news/275440926.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.